List of PMIDs

Current Target Information

HUGO ID 11892
Symbol TNF
Name tumor necrosis factor (TNF superfamily, member 2)
#Occurrence 475
#Paper 43



PMID TITLE # of Targets Links Journal
11173059Pharmacogenomics of neurodegenerative diseases.64Eur J Pharmacol
16647138Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders.59Brain Res Rev
16624536Innate immunity in amyotrophic lateral sclerosis.54Biochim Biophys Acta
17015226ALS: a disease of motor neurons and their nonneuronal neighbors.51Neuron
18513389New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background.42BMC Bioinformatics
17569578PPARs in the brain.42Biochim Biophys Acta
18464922Peroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington's Disease.35PPAR Res
18464925Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists.35PPAR Res
14739060Neurodegenerative diseases and oxidative stress.33Biomed Pharmacother
16753239Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders.32Neurochem Int
15572176A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis.27Brain Res Brain Res Rev
15081582Neuroinflammation, COX-2, and ALS--a dual role?25Exp Neurol
16510725Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis.24J Neurosci
17018025Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia.23J Neurochem
17582695Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?21Med Hypotheses
18040778Microglia as a pharmacological target in infectious and inflammatory diseases of the brain.20J Neuroimmune Pharmacol
17597167Inflammation in the nervous system--physiological and pathophysiological aspects.19Physiol Behav
17555556Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia.18J Neurochem
10525172Neurodegenerative disorders: the role of peroxynitrite.17Brain Res Brain Res Rev
15453089Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.17J Neuropathol Exp Neurol
17008387Pyrrolidine dithiocarbamate inhibits induction of immunoproteasome and decreases survival in a rat model of amyotrophic lateral sclerosis.16Mol Pharmacol
17350694The endocannabinoid system in targeting inflammatory neurodegenerative diseases.16Trends Pharmacol Sci
14960605Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis.15J Neurosci
15657392Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model.15J Cell Biol
17418957Tumor necrosis factor-alpha induces changes in mitochondrial cellular distribution in motor neurons.14Neuroscience
15649489Peroxisome proliferator-activated receptor-gamma agonist extends survival in transgenic mouse model of amyotrophic lateral sclerosis.14Exp Neurol
18436268Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1 G93A transgenic mice.12Neuropharmacology
16436205Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation.11J Neuroinflammation
12124437Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.9J Neurochem
16380619Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?7Neurology
9562310Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases.6J Neurol Sci
16909005Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis.6Neurodegener Dis
18246426Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India.6Neurochem Res
15681814New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists.5Ann N Y Acad Sci
18414597Altered Lipid Metabolism in Brain Injury and Disorders.5Subcell Biochem
18422522Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration: a link between inflammation and neuroprotection.5J Neurochem
18751914Altered lipid metabolism in brain injury and disorders.5Subcell Biochem
17034351On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis.4Antioxid Redox Signal
11796754Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis.3J Neurochem
15777251Estrogen and cytokines production - the possible cause of gender differences in neurological diseases.3Curr Pharm Des
18375019Interferon-gamma-dependent cytotoxic activation of human astocytes and astrocytoma cells.3Neurobiol Aging
11847479Tumor necrosis factor and motoneuronal degeneration: an open problem.1Neuroimmunomodulation
17908040TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets.1Curr Alzheimer Res